Context Therapeutics, Inc. (CNTX)
0.4676
-0.03
(-6.50%)
USD |
NASDAQ |
Aug 24, 16:00
0.4676
0.00 (0.00%)
After-Hours: 19:57
Context Therapeutics Enterprise Value : 3.203M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 3.203M |
| August 20, 2026 | 5.004M |
| August 19, 2026 | 2.046M |
| August 18, 2026 | 2.873M |
| August 17, 2026 | 5.978M |
| August 14, 2026 | 5.298M |
| August 13, 2026 | 3.782M |
| August 12, 2026 | 0.4286M |
| August 11, 2026 | 0.0519M |
| August 10, 2026 | -1.188M |
| August 07, 2026 | 1.724M |
| August 06, 2026 | 3.562M |
| August 05, 2026 | 20.93M |
| August 04, 2026 | 14.39M |
| August 03, 2026 | 12.76M |
| July 31, 2026 | 12.33M |
| July 30, 2026 | 13.05M |
| July 29, 2026 | 13.94M |
| July 28, 2026 | 11.52M |
| July 27, 2026 | 14.43M |
| July 24, 2026 | 13.68M |
| July 23, 2026 | 11.67M |
| July 22, 2026 | 13.61M |
| July 21, 2026 | 15.14M |
| July 20, 2026 | 13.85M |
| Date | Value |
|---|---|
| July 17, 2026 | 12.38M |
| July 16, 2026 | 13.72M |
| July 15, 2026 | 15.17M |
| July 14, 2026 | 14.49M |
| July 13, 2026 | 14.57M |
| July 10, 2026 | 17.24M |
| July 09, 2026 | 11.88M |
| July 08, 2026 | 11.98M |
| July 07, 2026 | 21.57M |
| July 06, 2026 | 15.84M |
| July 02, 2026 | 17.32M |
| July 01, 2026 | 13.14M |
| June 30, 2026 | 8.146M |
| June 29, 2026 | -1.223M |
| June 26, 2026 | -0.9563M |
| June 25, 2026 | -2.794M |
| June 24, 2026 | -1.324M |
| June 23, 2026 | 5.632M |
| June 22, 2026 | 3.628M |
| June 18, 2026 | 3.812M |
| June 17, 2026 | 0.8813M |
| June 16, 2026 | 5.503M |
| June 15, 2026 | 8.149M |
| June 12, 2026 | 73.47M |
| June 11, 2026 | 76.22M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Merck & Co., Inc. | 423.37B |
| ANI Pharmaceuticals, Inc. | 1.966B |
| Corcept Therapeutics, Inc. | 12.89B |
| Veru, Inc. | 21.90M |
| Johnson & Johnson | 679.08B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.56M |
| Total Expenses (Quarterly) | 14.56M |
| EPS Diluted (Quarterly) | -0.153 |
| Earnings Yield | -104.3% |
| Normalized Earnings Yield | -104.32 |